Alzheimer Disease Clinical Trial
Official title:
Negotiation Training to Optimize Caregiver Communication in Alzheimer's Disease
Verified date | May 2024 |
Source | Northwestern University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to design a Negotiation and Dispute Resolution (NDR) training intervention to improve communication and address resolution of conflicts that family caregivers of patients with cognitive impairment and/or Alzheimer's Disease (AD) frequently experience.
Status | Active, not recruiting |
Enrollment | 132 |
Est. completion date | March 31, 2025 |
Est. primary completion date | April 20, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years and older |
Eligibility | Inclusion Criteria: - Speak/read English; - Currently provide care-giving support (e.g. emotional, social, physical, task-related) to an adult over the age of 65; - Currently provide care-giving support at least 1 hour per week (e.g. may include grocery shopping, scheduling appointments, and transportation); - Currently involved in any decision-making related to the healthcare and support of this adult over the age of 65; - Score >2 on the 8-item Informant Interview to Differentiate Aging and Dementia (AD8); - Access to and the ability to use the internet to complete a series of online activities; and - Have a valid email address or the willingness to create one to access during the study Exclusion Criteria: - Less than 21 years old - Unable to speak and read English |
Country | Name | City | State |
---|---|---|---|
United States | Northwestern University Feinberg School of Medicine | Chicago | Illinois |
Lead Sponsor | Collaborator |
---|---|
Northwestern University | National Institute on Aging (NIA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Intervention Feasibility: Recruitment | Measuring the feasibility of the intervention by collecting study recruitment rates (# of people) | 3 months post-baseline | |
Other | Intervention Feasibility: Retention | Measuring the feasibility of the intervention by collecting study participant retention rates (# of people) | 3 months post-baseline | |
Other | Intervention Feasibility: Usability | Measuring the feasibility of the intervention by measuring the usability of the intervention as measured by the System Usability Scale (SUS), a 10-item measure of usability. | 3 months post-baseline | |
Other | Intervention Feasibility: Acceptability | Measuring the feasibility and acceptability of the intervention using the USE Scale, a 30-item measure of usefulness, satisfaction, ease of use, and ease of learning. | 3 months post-baseline | |
Other | Intervention Feasibility: Completion | Measuring the feasibility of the intervention by assessing completion of negotiation training exercises. | 3 months post-baseline | |
Other | Negotiation and Conflict | Caregiver negotiation processes and communication will be assessed using the Dutch Test for Conflict Handling (DUTCH), a widely used tool that measures aspects of conflict resolution pertaining to the negotiator. | 3 months post-baseline | |
Other | Negotiation Knowledge | Survey measuring caregiver knowledge of negotiation strategies | 3 months post-baseline | |
Other | Negotiation Utilization | Survey measuring caregiver utilization of negotiation strategies | 3 months post-baseline | |
Other | Program Assessment | Survey measuring the perception of the assigned intervention program, satisfaction, progress. Likert scale. Open-ended questions to obtain qualitative data on subjects' perception. | 3 months post-baseline | |
Primary | Well-being | Caregiver well-being as measured by the Positive Affect and Well-being scale for the Neurology Quality of Life (Neuro-QOL) | 1 months post-baseline | |
Secondary | Anxiety | PROMIS Ca Adult Item Bank Emotional distress-Anxiety.
The PROMIS Anxiety instruments measure self-reported fear (fearfulness, panic), anxious misery (worry, dread), and hyper-arousal (tension, nervousness, restlessness). |
3 months post-baseline | |
Secondary | Caregiver strain | Caregiver Strain Index
The Modified Caregiver Strain Index (MCSI) is a 13-question validated tool that measures strain related to care provision. It measures the following major domains: Financial, Physical, Psychological, Social and Personal. This instrument can be used to assess individuals of any age who have assumed the caregiving role for an older adult. |
3 months post-baseline | |
Secondary | Caregiver burden | Burden Scale for Family Caregivers (BSFC-s): a 10-item short version of the Burden Scale for Family Caregivers that detects the amount of burden perceived by the family caregiver. | 3 months post-baseline | |
Secondary | Fatigue | PROMIS Fatigue
The PROMIS Fatigue instruments evaluate a range of self-reported symptoms, from mild subjective feelings of tiredness to an overwhelming, debilitating, and sustained sense of exhaustion that likely decreases one's ability to execute daily activities and function normally in family or social roles. |
3 months post-baseline | |
Secondary | General self-efficacy | PROMIS General Self-Efficacy - Short Form | 3 months post-baseline | |
Secondary | Caregiving self-efficacy | PROMIS Care-giving Self Efficacy | 3 months post-baseline | |
Secondary | Emotional support | PROMIS Emotional Support - Short Form.
The PROMIS Emotional Support item bank assesses perceived feelings of being cared for and valued as a person; having confidant relationships. |
3 months post-baseline | |
Secondary | Informational support | PROMIS Informational Support - Short Form.
The PROMIS Informational Support item bank assesses perceived availability of helpful information or advice. |
3 months post-baseline | |
Secondary | Satisfaction with Social Roles/Activities | PROMIS Satisfaction with Social Roles/Activities | 3 months post-baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |